DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics 9: 311. 28. Vidakovics MLP, Paba J, Lamberti Y, Ricart CA, de Sousa MV, et al. (2007) Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res 6: 2518–2528. 29. Panina EM, Mattoo S, Griffith N, Kozak NA, Yuk MH, et al. (2005) A genome- wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species. Mol Microbiol 58: 267–279. 30. Kuwae A, Matsuzawa T, Ishikawa N, Abe H, Nonaka T, et al. (2006) BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in the type III-dependent necrotic cell death. J Biol Chem 281: 6589–6600. 31. French CT, Panina EM, Yea SH, Griffith N, Arambula DG, et al. (2009) The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol 11: 1735–1749. 32. Nogawa H, Kuwae A, Matsuzawa T, Abe A (2004) The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for formation on the host plasma membrane. J Bacteriol 186: 3806–3813. 33. Stibitz S (1998) IS481 and IS1002 of Bordetella pertussis create a 6-base-pair duplication upon insertion at a consensus target site. J Bacteriol 180: 4963–4966. 34. DeShazer D, Wood GE, Friedman RL (1994) Molecular characterization of catalase from Bordetella pertussis: identification of the katA promoter in an upstream insertion sequence. Mol Microbiol 14: 123–130. 35. Kozak NA, Panina EM, Miller JF (2007) Type III secretion in Bordetella subspecies. In: Locht C, ed. Bordetella: molecular microbiology. Norfolk, United Kingdom: Horizon Scientific Press. pp 119–140. 36. Han H-J, Kamachi K, Okada K, Toyoizumi-Ajisaka H, Sasaki Y, et al. (2008) Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine 26: 1530–1534. Differential Expression of BteA in B. Pertussis 37. Mooi FR, van Loo IHM, van Gent M, He Q, Bart MJ, et al. (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15: 1206–1213. 38. Craig NL, Craigie R, Gellert M, Lambowitz AM (2002) Mobile DNA II. Washington DC: ASM Press. 1204 p. 39. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32–40. 40. Caro V, Hot D, Guigon G, Hubans C, Arrive´ M, et al. (2006) Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect 8: 2228–2235. 41. Kaberdin VR, Bla¨si U (2006) Translation initiation and the fate of bacterial mRNAs. FEMS Microbiol Rev 30: 967–979. 42. Pradel E, Guiso N, Menozzi FD, Locht C (2000) Bordetella pertussis TonB, a Bvg- independent virulence determinant. Infect Immun 68: 1919–1927. 43. O’Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007–4021. 44. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850–858. 45. Stefanelli P, Sanguinetti M, Fazio C, Posteraro B, Fadda G, et al. (2006) Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates. J Clin Microbiol 44: 3397–3400. 46. Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, et al. (2001) Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci U S A 25: 11638–11643. PLoS ONE | www.plosone.org 10 March 2011 | Volume 6 | Issue 3 | e17797